Capilin Point Laboratories Q2 Results 2025 Highlights: Net Profit Rises by 18.08% & Revenue Up 10.54% YoY

Click and Sign Up to Get Live Updates on Q2 Results 

Capilin Point Laboratories Q2 Results FY26: During Q2 FY26, Capilin Point Laboratories’ profit increased 18.08% YoY, while revenue increased by 10.54% YoY. The company posted robust numbers, with Q2 PAT at ₹154.45 crores and revenue at ₹534.04 crores. Capilin Point Laboratories announced its Q2 results on 5th November 2025.  

Capilin Point Laboratories Q2 Results FY26: Extracts of FY25 & FY26

Capilin Point Laboratories Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

• Capilin Point Laboratories clocked Q2 FY26 consolidated revenue of ₹534.04 crores vs ₹483.10 crores. 
• On the profit front, Capilin Point Laboratories earned a consolidated PAT of ₹154.45 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹130.80 crore.
• According to the consolidated figures, Capilin Point Laboratories’ quarterly PAT increased by 18.08% YoY, while revenue increased by 10.54%.
• Capilin Point Laboratories clocked Q2 FY26 standalone revenue of ₹175.18 crores vs ₹207.93 crores. 
• On the profit front, Capilin Point Laboratories earned a standalone PAT of ₹102.59 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹105.74 crore.
• According to the standalone figures, Capilin Point Laboratories’ quarterly PAT decreased by 2.98% YoY, while revenue decreased by 15.75%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Capilin Point Laboratories Share Price Performance

On the opening bell on 7th November 2025, Capilin Point Laboratories shares opened at ₹2,003.00 per share. However, the initial gains have since eroded, and Capilin Point Laboratories shares are currently trading at ₹1,928.10 per share, which is lower than the opening price.    

Considering the long-term achievements, Capilin Point Laboratories shares have yielded returns of approximately -9.06% over the past years, and 5-year returns stand at 296.79%. Over the maximum timeframe, Capilin Point Laboratories shares delivered a 4,780.12% return to investors. 

What Analysts Expect Post Q2 Results?

Following Capilin Point Laboratories’ robust Q2 results, analysts expect its share price to rise. According to analysts, Capilin Point Laboratories’ share price is expected to reach ₹2,130.20 per share in the coming year; however, in a downturn, it could fall to ₹1,950.30 per share. However, one must ignore stock market volatility and invest in Capilin Point Laboratories’ shares after thorough research. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY

Inspira Enterprise India IPO Details: Everything You Should Know about 

Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY

HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY

BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here